1. Home
  2. BRTX vs AIFU Comparison

BRTX vs AIFU Comparison

Compare BRTX & AIFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • AIFU
  • Stock Information
  • Founded
  • BRTX 1997
  • AIFU 1998
  • Country
  • BRTX United States
  • AIFU China
  • Employees
  • BRTX N/A
  • AIFU N/A
  • Industry
  • BRTX Managed Health Care
  • AIFU
  • Sector
  • BRTX Health Care
  • AIFU
  • Exchange
  • BRTX Nasdaq
  • AIFU NYSE
  • Market Cap
  • BRTX 11.2M
  • AIFU 11.9M
  • IPO Year
  • BRTX N/A
  • AIFU 2007
  • Fundamental
  • Price
  • BRTX $1.85
  • AIFU $0.21
  • Analyst Decision
  • BRTX Strong Buy
  • AIFU
  • Analyst Count
  • BRTX 1
  • AIFU 0
  • Target Price
  • BRTX $18.00
  • AIFU N/A
  • AVG Volume (30 Days)
  • BRTX 48.0K
  • AIFU 568.0K
  • Earning Date
  • BRTX 03-27-2025
  • AIFU 04-15-2025
  • Dividend Yield
  • BRTX N/A
  • AIFU N/A
  • EPS Growth
  • BRTX N/A
  • AIFU N/A
  • EPS
  • BRTX N/A
  • AIFU 0.38
  • Revenue
  • BRTX $401,000.00
  • AIFU $324,923,970.00
  • Revenue This Year
  • BRTX $482.76
  • AIFU N/A
  • Revenue Next Year
  • BRTX $212.24
  • AIFU $11.81
  • P/E Ratio
  • BRTX N/A
  • AIFU $0.55
  • Revenue Growth
  • BRTX 175.03
  • AIFU N/A
  • 52 Week Low
  • BRTX $1.03
  • AIFU $0.20
  • 52 Week High
  • BRTX $2.55
  • AIFU $4.87
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 53.36
  • AIFU N/A
  • Support Level
  • BRTX $1.72
  • AIFU N/A
  • Resistance Level
  • BRTX $1.85
  • AIFU N/A
  • Average True Range (ATR)
  • BRTX 0.13
  • AIFU 0.00
  • MACD
  • BRTX 0.02
  • AIFU 0.00
  • Stochastic Oscillator
  • BRTX 50.98
  • AIFU 0.00

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIX Inc is a technology-driven financial services provider company in China. It is an intelligent platform that creates a supportive and collaborative environment and provides solutions that integrate technology, products, services, operations, capital, and professional support for individual agents and sales organizations. The group uses technology, AI, and data-driven insights, pioneering the financial services that are delivered, its transformation, and empowering industry development. It connects customers with financial institutions, investment opportunities, and service providers, offering insurance, wealth management, and other value-added services.

Share on Social Networks: